Abimmune Biopharma Inc. Completes Convertible Note Financing

Represented Abimmune Biopharma Inc. in connection with its Convertible Note Financing. Abimmune Biopharma is a startup company that focuses on generating novel nanobody based drug candidates against a wide spectrum of high-value immunomodulatory and oncology targets related to T lymphocytes, solid tumors, and tumor stem cells.